Caesarstone Ltd Dossier - Source-backed chat

Caesarstone Ltd

CSTENASDAQ

SectorIndustrials

IndustryBuilding Products

Beta (adjusted)0.57

Intrinsic Value $3.69median of 2 methodsbased on filings through 31 Dec 2025

Market Price $2.78Price as of 1 Oct 2026

UndervaluedIntrinsic value is 33% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $96.1M

Enterprise Value $145M

Shares Outstanding 34.6M diluted

Next Earnings Date11 Nov 2026

Last ex-dividend16 Aug 2022

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Caesarstone is undergoing a major structural transformation, transitioning from an asset-heavy manufacturing footprint to an asset-light, third-party production model. While the closure of its Bar-Lev facility in Israel and other restructuring actions have successfully expanded gross margins (up 100 bps YoY to 22.3% in Q1 2026), the company continues to face severe top-line pressure. Global revenue fell 14.9% YoY on a constant-currency basis in Q1 2026 due to macroeconomic headwinds, high interest rates, and intense competition. Although management remains on track to achieve positive Adjusted EBITDA in Q3 2026, persistent legal risks from over 700 silica-related injury lawsuits and ongoing tariff uncertainties warrant a cautious Hold stance until top-line stabilization and sustainable profitability are demonstrated.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$1.0015%

Macroeconomic conditions deteriorate further, prolonging the downturn in home renovation and construction. Sourcing from third-party partners fails to offset rising freight costs and potential new U.S. import tariffs. Additionally, adverse judgments or escalating settlement costs from the 711 active silica-related lawsuits severely drain cash reserves, delaying the return to positive EBITDA.

Base CaseCentral scenario

$2.0060%

Caesarstone successfully achieves positive Adjusted EBITDA in Q3 2026 as projected, supported by disciplined cost controls and the realization of restructuring benefits. However, global revenue remains flat to slightly down due to slow recovery in residential construction and persistent competitive pricing pressures. Legal liabilities and tariff headwinds remain manageable but cap significant valuation upside.

Bull CaseUpside scenario

$4.0025%

The transition to third-party manufacturing partners accelerates margin recovery faster than anticipated, yielding over $100 million in annualized cash savings by 2027. A rapid recovery in global housing markets and remodeling demand drives strong adoption of Caesarstone's premium, sustainable, and zero-silica offerings (such as the Caesarstone ICON line), particularly in high-margin regions like Australia and North America.

Scenarios reflect our research view at the research date.

Key Investment Merits

Asset-light operational model following the closure of the Bar-Lev facility, significantly reducing fixed overhead.
Strong balance sheet with a net cash position of $50.4 million and minimal debt of $1.8 million as of March 31, 2026.
Product innovation leadership, highlighted by the launch of Caesarstone ICON, a zero-crystalline silica surface made with ~85% recycled materials.

Key Investment Risks

Severe litigation exposure with 711 active lawsuits globally regarding alleged silica-related bodily injuries.
Top-line vulnerability to macroeconomic cycles, high interest rates, and depressed home turnover rates.
Geopolitical risks in Israel affecting local demand and increasing logistics and product costs.

Thesis Invalidation Triggers

Failure to achieve positive Adjusted EBITDA by the third quarter of 2026.
A material increase in legal provisions or negative court rulings related to silicosis litigation.
Imposition of highly restrictive U.S. customs tariffs on imported quartz surfaces that cannot be mitigated.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.